πŸ‡ΊπŸ‡Έ FDA
Patent

US 10463734

Nanoparticle therapy in cancer

granted A61KA61K33/24A61K33/243

Quick answer

US patent 10463734 (Nanoparticle therapy in cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K33/24, A61K33/243, A61K33/244, A61K33/26